NationalCovid Jab Covovax As Heterologous Booster To Be Available On CoWIN Soon; To Cost Rs 225 Per DoseBY PTI
NationalSerum Institute Seeks Inclusion Of Covovax On CoWIN As Heterologous Booster Dose For AdultsBY PTI
NationalCovovax Booster Dose For Covid-19, Its Efficacy Rate And How Does It Work? All You Need To KnowBY Outlook Web Desk
National DCGI Approves Market Authorisation For SII's Covid Vaccine Covovax As Heterologous Booster DoseBY PTI
NationalDCGI Approves Market Authorisation For SII's Covid Vaccine Covovax As Heterologous Booster DoseBY PTI
NationalGovernment Panel Likely To Decide On Covovax As A Heterologous Booster Dose For Adults On WednesdayBY PTI
NationalCovid-19: Covovax To Get Approval As Booster In 10-15 Days, Says SII CEO Adar PoonawallaBY PTI
NationalSerum Institute Seeks Drug Regulator's Approval For Market Authorisation Of Its Covid Vaccine As Booster DoseBY PTI
NationalDay After DCGI's Nod, SII Seeks Inclusion Of Covovax In Covid Immunisation ProgrammeBY Outlook Web Desk
NationalDCGI Approves Indigenous mRNA Covid Jab For Emergency Use In 18 Years & Above; Covovax For 7-11 yearsBY
NationalGovt Panel Recommends Inclusion Of Covovax In National COVID-19 Vaccination Drive For Those Aged 12 And AboveBY Outlook Web Desk
NationalNTAGI's COVID Working Group To Review SII's Covovax Data For Use In 12 Year Olds And AboveBY Outlook Web Desk
NationalCovid: Govt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In AdultsBY Outlook Web Desk
NationalCovid-19: Corbevax, Covovax Approval Brings Spotlight On India-US CollaborationBY Outlook Web Desk
NationalCovovax approval to strengthen immunization efforts in India, lower- & middle-income countries: SIIBY Outlook Web Desk
NationalCovid-19 Vaccines: Expert Panel Recommends EUA For Covovax, Corbevax & Molnupiravir PillsBY Outlook Web Desk
